Latest Breaking News On - Managing director sushil suri - Page 1 : comparemela.com

Morepen gets USFDA nod to market generic anti-allergy drug - Jammu Kashmir Latest News | Tourism

NEW DELHI, Dec 3: Drug firm Morepen Laboratories on Friday said it has received approval from the US health regulator to market its anti-allergy drug Fexofinadine Hydrochloride in the American market. The company sells the product in India under the brand name Allegra. Morepen’s product is the generic version of Sanofi Aventis’ anti- allergy drug. Fexofinadine is the most widely used, second generation antihistamine drug for the treatment of allergy symptoms and hay fever. In a statement, the company said […]

United statesNew zealandBaddi himachal pradeshFexofinadine allegraSanofi aventiMorepen laboratoriesFexofinadine hydrochlorideManaging director sushil suriHimachal pradeshActive pharmaceutical ingredient

Morepen shareholders approve new unit to house medical device biz

Morepen shareholders approve new unit to house medical device biz

Morepen devices ltdMorepen laboratoriesMedical devices businessMorepen devicesLaboratories chairmanManaging director sushil suriMorepen shareholdersMorepen new unit to house medical deviceMorepen 039s medical device bizMorepen laboratories cmd sushil suri

Morepen shareholders approve new unit to house medical device biz

Morepen shareholders approve new unit to house medical device biz
dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.

Morepen devices ltdMorepen laboratoriesMedical devices businessMorepen devicesLaboratories chairmanManaging director sushil suri

Can produce 250 mn doses of Sputnik V every year: Morepen India CMD

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : The monthly duration product is an auto renewal based product. Once subscribed, subject to your card issuer s permission we will charge your card/ payment instrument each month automatically and renew your subscription. In the Annual duration product we offer both an auto renewal based product and a non auto renewal based product.

Uddalok bhattacharyaRussian direct investment fundMorepen india chairmanManaging director sushil suriStandard digitalBusiness standardSeamless sign upBusiness standard digitalDebit cardsNet bankingPayment walletsரஷ்ய நேரடி முதலீடு நிதிநிர்வகித்தல் இயக்குனர் சுஷில் சூரிதரநிலை டிஜிட்டல்வணிக தரநிலைதடையற்ற அடையாளம் மேலே

Top Headlines: Zomato heads for more indices; chip crisis costs millions

Zomato could get added to the MSCI and FTSE indices by the end of this year, while an entry to the Nifty or the Sensex would be challenging before the second half of 2022, said an analyst. Public sector banks moving to invoke personal guarantees of promoters of defaulting companies face a highly litigious path. Here is what s making news Thursday morning. Zomato could get added to MSCI, FTSE indices by 2021-end: Analyst Zomato could get added to the MSCI and FTSE indices by the end of this year, while an entry to the Nifty or the Sensex would be challenging before the second half of 2022, said Brian Freitas, an analyst at independent research provider Smartkarma, in note. Newly-listed companies can get added to the SCI India index and the MSCI Global Investable Market Indexes (GIMI) under the so-called ‘fast entry’ route provided they meet the market cap criteria.

Uddalok bhattacharyaBrian freitasTata motorsNational company law tribunalUnion cabinet onInvestable market indexesGeneral motorsMorepen indiaIndia chairmanManaging director sushil suriUnion cabinetபிரையன் ஃப்ரீடாஸ்டாடா மோட்டார்கள்தேசிய நிறுவனம் சட்டம் தீர்ப்பாயம்தொழிற்சங்கம் மந்திரி சபை ஆன்ஜநரல் மோட்டார்கள்